|
|
|
|
|
|
|
|
|
|
Clinigen Release Company Initiates U S Managed Access Program For Tesaros Niraparib For Patients With Ovarian Cancer
1/17/2017
The Managed Access program allows physicians to request niraparib for individual, eligible U.S. patients who may not be able to participate in a clinical trial nor have any other treatment option, but who may benefit from access to this investigational therapy prior to approval.
0 comments :
Post a Comment
Your comments?
Note: Only a member of this blog may post a comment.